Research Article
The Hasford Score May Predict Molecular Response in Chronic Myeloid Leukemia Patients: A Single Institution Experience
Figure 5
Cumulative probability of achieving MR4.0 on 2G-TKI treatment assessed by Hasford risk score (LR, low-risk group, IR, intermediate-risk group).